Free to join. Every idea is scored for your budget, hours and skills; starting one is Pro.
71
Good
The public score: the same for everyone. Members also see how well it fits them.
What you could build
The offerA curated newsletter that delivers expert‑written analysis of current and emerging life‑science topics
Who paysReaders who want reliable, easy‑to‑understand updates on biotech, pharma and health‑tech breakthroughs
First versionA simple sign‑up page and weekly email featuring 2–3 expert articles hand‑picked and summarized by the founder
One way to serve the need, not the only one.
Why it scores 71
Demand74Fourteen asked in thirty days; reading on the subject up 100% on the month.
Timing57Five this month against nine in the two before.
Market gap65Not measured yet: we have seen nothing written on it, and we read a narrow slice of what is sold.
Evidence84Two independently run sources.
We show real demand. We never estimate what you'll earn.
PotentialModestPotential describes the market we observed. It is not a prediction of what you will earn.
How we know
Fourteen people asked for this in the last thirty days.
They came from two independently run sources, not one list.
Every fact above comes from something we observed and kept, never from an estimate. How Colaunched finds ideas
Ask your assistant
Claude, ChatGPT or any MCP client can read this idea and the rest with no account: add mcp.colaunched.ai/public as a connector and ask what people are asking for in media & entertainment. How it works
What we don't know
Whether anyone will pay for it. No signal can tell us that. The first gate in a launch is there to find out.